Show simple item record

dc.contributor.authorUsher-Smith, JA
dc.contributor.authorKassianos, AP
dc.contributor.authorEmery, JD
dc.contributor.authorAbel, GA
dc.contributor.authorTeoh, Z
dc.contributor.authorHall, S
dc.contributor.authorNeal, RD
dc.contributor.authorMurchie, P
dc.contributor.authorWalter, FM
dc.date.accessioned2019-02-08T14:23:04Z
dc.date.issued2016-12-23
dc.description.abstractBackground: Melanoma incidence is rising rapidly worldwide among white populations. Defining higher-risk populations using risk prediction models may help targeted screening and early detection approaches. Objectives: To assess the feasibility of identifying people at higher risk of melanoma using the Williams self-assessed clinical risk estimation model in U.K. primary care. Methods: We recruited participants from the waiting rooms of 22 general practices covering a total population of > 240 000 in three U.K. regions: Eastern England, North East Scotland and North Wales. Participants completed an electronic questionnaire using tablet computers. The main outcome was the mean melanoma risk score using the Williams melanoma risk model. Results: Of 9004 people approached, 7742 (86%) completed the electronic questionnaire. The mean melanoma risk score for the 7566 eligible participants was 17·15 ± 8·51, with small regional differences [lower in England compared with Scotland (P = 0·001) and Wales (P < 0·001), mainly due to greater freckling and childhood sunburn among Scottish and Welsh participants]. After weighting to the age and sex distribution, different potential cut-offs would allow between 4% and 20% of the population to be identified as higher risk, and those groups would contain 30% and 60%, respectively of those likely to develop melanoma. Conclusions: Collecting data on the melanoma risk profile of the general population in U.K. primary care is both feasible and acceptable for patients in a general practice setting, and provides opportunities for new methods of real-time risk assessment and risk stratified cancer interventions.en_GB
dc.description.sponsorshipNational Institute for Health Research (NIHR)en_GB
dc.identifier.citationVol. 176, pp. 939 - 948en_GB
dc.identifier.doi10.1111/bjd.15181
dc.identifier.grantnumberRG 68235en_GB
dc.identifier.urihttp://hdl.handle.net/10871/35866
dc.language.isoenen_GB
dc.publisherWiley / British Association of Dermatologistsen_GB
dc.rights© 2016 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.en_GB
dc.titleIdentifying people at higher risk of melanoma across the U.K.: a primary-care-based electronic surveyen_GB
dc.typeArticleen_GB
dc.date.available2019-02-08T14:23:04Z
dc.identifier.issn0007-0963
dc.descriptionThis is the final version. Available from the publisher via the DOI in this record.en_GB
dc.identifier.journalBritish Journal of Dermatologyen_GB
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/en_GB
dcterms.dateAccepted2016-08-11
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2016-12-23
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2019-02-08T14:19:59Z
refterms.versionFCDVoR
refterms.dateFOA2019-02-08T14:23:07Z
refterms.panelAen_GB
refterms.depositExceptionpublishedGoldOA
refterms.depositExceptionExplanationhttps://doi.org/10.1111/bjd.15181


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2016 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.

This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Except where otherwise noted, this item's licence is described as © 2016 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.